Be the first to like this
In this video, Adrian Towse discusses the challenges and importance of appropriately valuing genomic medicine. He addresses both gene therapies and “pharmacogenomics” -- those medicines that will allow targeted, precision treatment. He points out the importance, with respect to the latter, of the importance of appropriately valuing the diagnostics that are essential to realising the full value of treatment.
This video is from the Translation Genomics Event presented by the NHS’s National Genetics Education and Development Centre.